i want to change my class description . . .
the "CLASS" shall be described as:
"shareholders who buy based SOLELY on one PR, and within 24 hours sell SOLELY based on adam F"
it's too narrow . . . no class certified, jmo . . .
evidence #1 babcock's PR
evidence #2 adam's PR
imo, the "CLASS" shall be described as "shareholders who sell SOLELY based on adam F" . . .
the judge may toss this one out . . .
please copy and paste the text you consider worthy of a CA filing . . . AF claimed babcock lied . . . here are the paragraphs with his quotes . . .
THERE IS NO OTHER EVIDENCE!!!
RICHLAND, WA--(Marketwired - May 20, 2015) - IsoRay, Inc. (NYSE MKT: ISR), a medical technology company and innovator in seed brachytherapy and medical radioisotope applications, today announced the on-line publication of the first major peer reviewed study showing improved results using IsoRay's Cesium-131 seeds in the treatment of lung cancer.
IsoRay CEO Dwight Babcock commented, "We are extremely excited to have our Cesium-131 isotope seeds and mesh used in the treatment of non-small cell lung cancers with such outstanding patient outcomes. Notable physicians, including the authors of this study, are seeking better solutions and outcomes for their patients. We are continuing to develop our product offerings internally with support from these industry leaders. With every success that has been reported, the medical community is rapidly becoming aware of the innovative alternative our Cesium-131 products offer to cancer patients."
Babcock said, "Published studies are the final step to commercialization as leaders in the medical arena recognize the important need for a new powerful weapon in the battle against cancer. This latest
btw, i read babcock's PR, did you? . . . i see no lying in there . . . please tell the board what he lied about . . . maybe AF was lying . . . this is PR v. PR . . . it's not about the peer review . . .
the worst case scenario is a 2.5 mil insurance settlement in about 2 years . . . together we can all wait to see who is right . . . i'm sure the street has insurance too . . . stop worrying . . . CAs are a common nuisance, that;s all, is this your first stock?
they have insurance . . . there are 10 ambulance chasers trying to be the lead on the ONE LAWSUIT . . . it will cost nothing until settled . . .
YES, it will go away, after a year or two of lawyer's dancing with each other . . .
if that happens i will tip my hat to you . . . and not tip you, mooooo . . . a move to OTC is usually proceeded with toxic financing, in a 8k most shareholders won't read . . . if it happens, i will . . . until then, have a nice graze this summer, and fatten up . . . the slaughter should happen in the fall . . .
oops there, not their . . . lolol . . .
if the treated cancer never returns, isn't the patient cured? . . .
let's try to look past your language barrier . . . person dying, still living . . .
does that help? . . .
the constant stream of PR is proving their is growing interest . . . how much?, who knows . . . but it's growing, not waning . . . give it another year and see where we are . . . patience my bovine friend . . .
i get it . . . there are too many trees in the way so you can't see the forest . . . this is the 33nd time i've had to tell you, lol . . .
if the class is certified, there will be a cross-complaint to the street, claiming, "yes the shareholders were damaged, but by a different party" . . . if the class is not certified, they will file a new case for defamation . . .
i'm surprised that all of the scientists and doctors that are testing and curing cancer, as well as the crack TV and news reporters all collectively missed this typo . . .
great DD . . . the word "you" is missing . . . a word you can't seem to grasp, lol . . . no wonder YOU found the typo . . .
i can't thank AF enough for the buying op at 1.45 . . . as for the 6.5 mil shorts, how much lower were they hoping for . . . the HP was well over a month ago and 1.40's held . . . worse case, a lead P will be declared in a few weeks, and it goes to the lawyers to discuss for the next two years . . .
maybe it's time to spring for another HP, i have more money waiting . . . thanks again . . .
i can't believe that they think people trade based on an anonymous message board poster, lol . . . delusions of grandeur i guess . . . at least they have a job, i don't mind their ranting . . . the PR keeps coming, and the shorts are now stuck . . . time fixes all . . .
check out the name of the radient pharma board (was RXPC)
Радиент Фарм ЦП Message Board
i guess yahoo is from serbia . . .
of course the best trick is the total shutdown of this SQNM board for years, AND NOT ONE PERSON AT YAHOO HAS THE BRAINS TO STOP THE BOT . . . FOR YEARS, lololol . . .
ehh, i was bored waiting for the day's heat to subside . . . and he really does need to learn anyway . . .
NO, not if it's trading over a buck or two . . . you must be dumber than a yak . . . perhaps a water buffalo? . . .
this is not a game show, repeat, this is not a game show . . .
but as a gesture of kindness to our favorite bovine, and to MOVE THE CONVERSATION ALONG . . .
it sounds like you were bagged buying JUNO for 50+, with the hope of a product sometime around 2020 . . . you can tell by all the talking head press it's getting . . . maybe crammmer told you to buy buy buy. lol . . . .
when JUNO is trading at a buck in 2019, i'll buy it then, if the intrinsic value you paid for still exists . . . welcome to wall street . .
and since you think you're a genius . . . comparing JUNO to ISR
- which has the higher book value?
- which has the greater earnings?
- which has FDA approval NOW?
- who's hoping for a product in the next decade?
still, it's good for someone who yaks so much to learn this lesson, 50 bucks for a company losing 13.- a year, and a ZERO book value, with no product for 5 years at least . . . . oh, they only got 150m up front, lol . . .
i never looked you silly bovine, why would i? . . . are you a wannabe game show host? . . . i named my stock . . . it wasn't hard . . .
but i can guess this stock of yours trades higher than 1.45 . . . right? . . . 'cmon, moo us up an answer . . . yak, yak, yak . . .